Paradigm Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-300
Closed -$164K 433
2022
Q1
$164K Hold
300
0.04% 299
2021
Q4
$198K Hold
300
0.05% 298
2021
Q3
$187K Sell
300
-100
-25% -$67.2K 0.05% 307
2021
Q2
$253K Sell
400
-100
-20% -$55.2K 0.06% 310
2021
Q1
$245K Sell
500
-100
-17% -$50.1K 0.07% 312
2020
Q4
$300K Buy
+600
New +$268K 0.08% 310

Other funds holding IDXX

Paradigm Asset Management's IDXX Position: Q2 2022 in Review

Paradigm Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 300 shares — an estimated $164K sold.

Paradigm Asset Management first reported a position in IDXX in Q4 2020 and held it in 6 quarters. The position peaked at $300K in Q4 2020. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Paradigm Asset Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Paradigm Asset Management sold 300 Idexx Laboratories shares in Q2 2022, an estimated $164K.
  • Paradigm Asset Management first reported a position in Idexx Laboratories in Q4 2020 and held it in 6 quarters.
  • Paradigm Asset Management's Idexx Laboratories position peaked at $300K in Q4 2020.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Paradigm Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.